Insider Trading Activity For Coherus BioSciences, Inc. (NASDAQ:CHRS)
Alan C Herman , Insider of Coherus BioSciences, Inc. (NASDAQ:CHRS) reportedly Sold 17,535 shares of the company’s stock at an average price of 15.02 for a total transaction amount of $263,375.70 SEC Form
Insider Trading History For Coherus BioSciences, Inc. (NASDAQ:CHRS)
Analyst Ratings For Coherus BioSciences, Inc. (NASDAQ:CHRS)
These are 9 Buy Ratings .
The current consensus rating for Coherus BioSciences, Inc. (NASDAQ:CHRS) is Buy (Score: 3.00) with a consensus target price of $37.00 , a potential (221.04% upside)
Analyst Ratings History For Coherus BioSciences, Inc. (NASDAQ:CHRS)
- On 11/25/2016 Standpoint Research Initiated Coverage of rating Buy with a price target of $40.00
- On 5/21/2017 Barclays PLC Reiterated Rating Overweight with a price target of $46.00
- On 6/12/2017 Maxim Group Lower Price Target of rating Buy to Buy with a price target of $44.00 to $40.00
- On 6/13/2017 Robert W. Baird Lower Price Target of rating Outperform with a price target of $40.00 to $37.00
- On 6/13/2017 BMO Capital Markets Lower Price Target of rating Outperform with a price target of $54.00 to $43.00
- On 6/13/2017 Cowen and Company Reiterated Rating Outperform with a price target of $45.00
- On 6/13/2017 Citigroup Inc Lower Price Target of rating Buy with a price target of $38.00 to $33.00
Recent Trading Activity for Coherus BioSciences, Inc. (NASDAQ:CHRS)
Shares of Coherus BioSciences, Inc. closed the previous trading session at 11.52 down -1.08 -8.53% with 617,815 shares trading hands.